Symbols / COCH $0.68 -3.05% Envoy Medical, Inc.

Healthcare • Medical Devices • United States • NCM
COCH Chart
About

Envoy Medical, Inc., a hearing health company, focuses on providing medical technologies across the hearing loss spectrum. The company's medical technologies are designed to shift the paradigm within the hearing industry and bring providers and patients the hearing devices desire. It offers personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants. The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023. Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Medical Devices Market Cap 52.55M
Enterprise Value 49.73M Income -28.66M Sales 241.00K
Book/sh -0.41 Cash/sh 0.05 Dividend Yield
Payout 0.00% Employees 43 IPO
P/E Forward P/E -2.28 PEG
P/S 218.04 P/B -1.68 P/C
EV/EBITDA -2.28 EV/Sales 206.34 Quick Ratio 0.33
Current Ratio 0.54 Debt/Eq LT Debt/Eq
EPS (ttm) -1.23 EPS next Y -0.30 EPS Growth
Revenue Growth 78.60% Earnings 2025-11-10 08:00 ROA -137.34%
ROE ROIC Gross Margin -183.82%
Oper. Margin -82.60% Profit Margin 0.00% Shs Outstand 76.88M
Shs Float 45.78M Short Float 1.23% Short Ratio 1.87
Short Interest 52W High 1.91 52W Low 0.36
Beta 2.05 Avg Volume 781.67K Volume 299.39K
Target Price $2.50 Recom Strong_buy Prev Close $0.70
Price $0.68 Change -3.05%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$2.50
Mean price target
2. Current target
$0.68
Latest analyst target
3. DCF / Fair value
$-1.90
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.68
Low
$2.50
High
$2.50
Mean
$2.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-31 init HC Wainwright & Co. — → Buy $3
2025-05-27 main Ascendiant Capital Buy → Buy $10
2025-04-21 main Ascendiant Capital Buy → Buy $9
2024-12-06 main Ascendiant Capital Buy → Buy $9
2024-10-14 init Brookline Capital — → Buy $9
2024-09-03 main Ascendiant Capital Buy → Buy $9
2024-06-24 init Ascendiant Capital — → Buy $9
2024-04-03 main Lake Street Buy → Buy $6
2023-12-21 init Northland Capital Markets — → Outperform
2023-11-28 init Lake Street — → Buy $3
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-02-12 TAYLOR GLEN ALBERT Beneficial Owner of more than 10% of a Class of Security 18,750,000 $0.52 $9,830,625
2026-02-12 KANTOR SUSAN J. Director 96,150 $0.52 $50,411
2026-02-12 BRYNELSEN CHARLES R Director 1,000,000 $0.52 $524,300
2026-02-12 POTASHNICK ROBERT Chief Financial Officer 212,500 $0.52 $111,414
2026-02-12 LUCAS BRENT T Chief Executive Officer 62,500 $0.52 $32,769
2026-02-12 PATEL MONA CHETAN Director 312,500 $0.52 $163,844
2025-11-28 LUCAS BRENT T Chief Executive Officer 18,105 $0.71 $12,909
2025-06-11 PATEL MONA CHETAN Director 2,500 $1.47 $3,675
2025-06-06 PATEL MONA CHETAN Director 10,000 $1.46 $14,600
2025-05-30 LUCAS BRENT T Chief Executive Officer 12,907 $1.29 $20,028
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.24
+7.11%
0.23
-28.80%
0.32
+33.33%
0.24
Operating Revenue
0.24
+7.11%
0.23
-28.80%
0.32
+33.33%
0.24
Cost Of Revenue
0.87
+17.79%
0.74
-5.96%
0.79
+58.43%
0.50
Reconciled Cost Of Revenue
0.87
+17.79%
0.74
-5.96%
0.79
+58.43%
0.50
Gross Profit
-0.63
-22.44%
-0.52
-9.30%
-0.47
-81.23%
-0.26
Operating Expense
21.64
+15.47%
18.74
+4.77%
17.89
+111.79%
8.45
Research And Development
12.49
+22.66%
10.18
+13.66%
8.96
+80.02%
4.97
Selling General And Administration
9.15
+6.90%
8.56
-4.14%
8.93
+157.35%
3.47
Selling And Marketing Expense
1.22
-29.64%
1.73
+4.08%
1.67
+88.25%
0.89
General And Administrative Expense
7.93
+16.19%
6.83
-6.03%
7.26
+181.01%
2.58
Other Gand A
7.93
+16.19%
6.83
-6.03%
7.26
+181.01%
2.58
Total Expenses
22.51
+15.55%
19.48
+4.32%
18.68
+108.82%
8.94
Operating Income
-22.27
-15.65%
-19.26
-4.89%
-18.36
-110.88%
-8.71
Total Operating Income As Reported
-22.27
-15.65%
-19.26
-4.89%
-18.36
-110.88%
-8.71
EBITDA
-21.86
-10.39%
-19.81
+33.51%
-29.79
-245.14%
-8.63
Normalized EBITDA
-21.99
-15.08%
-19.11
+39.34%
-31.50
-265.01%
-8.63
Reconciled Depreciation
0.30
+74.57%
0.17
+30.08%
0.13
+77.33%
0.07
EBIT
-22.17
-10.95%
-19.98
+33.23%
-29.92
-243.69%
-8.71
Total Unusual Items
0.13
+118.22%
-0.70
-140.64%
1.72
Total Unusual Items Excluding Goodwill
0.13
+118.22%
-0.70
-140.64%
1.72
Net Income
-23.76
-14.24%
-20.80
+30.50%
-29.92
-87.92%
-15.92
Pretax Income
-23.76
-14.24%
-20.80
+30.50%
-29.92
-87.92%
-15.92
Net Non Operating Interest Income Expense
-1.59
-94.85%
-0.82
0.00
Interest Expense Non Operating
1.59
+94.85%
0.82
0.00
Net Interest Income
-1.59
-94.85%
-0.82
0.00
Interest Expense
1.59
+94.85%
0.82
0.00
Other Income Expense
0.10
+114.38%
-0.72
+93.75%
-11.56
-60.22%
-7.22
Other Non Operating Income Expenses
-0.02
+11.54%
-0.03
+99.80%
-13.28
-83.98%
-7.22
Gain On Sale Of Security
0.13
+118.22%
-0.70
-140.64%
1.72
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-23.76
-14.24%
-20.80
+30.50%
-29.92
-87.92%
-15.92
Net Income From Continuing Operation Net Minority Interest
-23.76
-14.24%
-20.80
+30.50%
-29.92
-87.92%
-15.92
Net Income From Continuing And Discontinued Operation
-23.76
-14.24%
-20.80
+30.50%
-29.92
-87.92%
-15.92
Net Income Continuous Operations
-23.76
-14.24%
-20.80
+30.50%
-29.92
-87.92%
-15.92
Normalized Income
-23.88
-18.83%
-20.10
+36.47%
-31.64
-98.69%
-15.92
Net Income Common Stockholders
-28.66
-2.46%
-27.97
+10.55%
-31.27
-96.39%
-15.92
Otherunder Preferred Stock Dividend
0.00
-100.00%
1.66
0.00
Diluted EPS
-1.49
+41.34%
-2.54
-61.97%
-1.57
Basic EPS
-1.49
+41.34%
-2.54
-61.97%
-1.57
Basic Average Shares
18.79
+52.83%
12.30
+21.09%
10.15
Diluted Average Shares
18.79
+52.83%
12.30
+21.09%
10.15
Diluted NI Availto Com Stockholders
-28.66
-2.46%
-27.97
+10.55%
-31.27
-96.39%
-15.92
Preferred Stock Dividends
4.91
-11.14%
5.52
+309.27%
1.35
-32.55%
2.00
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
8.56
-25.83%
11.54
+39.50%
8.27
+223.59%
2.56
Current Assets
6.28
-29.42%
8.90
+19.31%
7.46
+352.43%
1.65
Cash Cash Equivalents And Short Term Investments
3.74
-31.81%
5.48
+29.99%
4.22
+2204.92%
0.18
Cash And Cash Equivalents
3.74
-31.81%
5.48
+29.99%
4.22
+2204.92%
0.18
Cash Financial
3.74
-31.81%
5.48
+29.99%
4.22
+2204.92%
0.18
Receivables
0.05
-93.52%
0.82
+232.52%
0.25
+500.00%
0.04
Accounts Receivable
0.03
-10.53%
0.04
-45.71%
0.07
+70.73%
0.04
Other Receivables
0.02
-97.56%
0.78
+343.18%
0.18
Inventory
1.55
-9.48%
1.71
+21.65%
1.40
+8.42%
1.29
Raw Materials
1.26
-8.95%
1.39
+19.28%
1.16
+15.05%
1.01
Work In Process
0.09
-56.65%
0.20
+28.48%
0.16
-3.66%
0.16
Finished Goods
0.20
+64.71%
0.12
+41.67%
0.08
-30.58%
0.12
Prepaid Assets
0.13
Other Current Assets
0.94
+6.09%
0.89
-44.14%
1.59
+1131.01%
0.13
Total Non Current Assets
2.28
-13.74%
2.64
+224.17%
0.81
-10.24%
0.91
Net PPE
1.92
-10.82%
2.15
+164.29%
0.81
-10.24%
0.91
Gross PPE
7.03
+0.66%
6.98
+27.63%
5.47
+502.64%
0.91
Accumulated Depreciation
-5.11
-5.78%
-4.83
-3.71%
-4.66
-2.83%
-4.53
Properties
0.00
0.00
0.00
Buildings And Improvements
0.89
+0.80%
0.88
+89.44%
0.46
Machinery Furniture Equipment
0.76
+0.67%
0.75
+0.00%
0.75
-0.53%
0.75
Construction In Progress
4.11
Other Properties
5.39
+0.63%
5.36
+25.76%
4.26
+368.94%
0.91
Non Current Prepaid Assets
0.36
-26.64%
0.49
Total Liabilities Net Minority Interest
20.32
-33.10%
30.38
+202.38%
10.05
-74.07%
38.75
Current Liabilities
11.56
+53.38%
7.54
+3.47%
7.29
+189.20%
2.52
Payables And Accrued Expenses
10.56
+74.01%
6.07
-1.61%
6.17
+282.81%
1.61
Payables
8.63
+422.15%
1.65
+6.31%
1.55
+54.94%
1.00
Accounts Payable
2.92
+76.76%
1.65
+6.31%
1.55
+54.94%
1.00
Dividends Payable
3.78
Current Accrued Expenses
1.93
-56.23%
4.42
-4.27%
4.61
+658.72%
0.61
Total Tax Payable
1.93
0.01
Current Debt And Capital Lease Obligation
0.17
+21.68%
0.14
-9.49%
0.16
-72.43%
0.57
Current Debt
0.45
Other Current Borrowings
0.45
Current Capital Lease Obligation
0.17
+21.68%
0.14
-9.49%
0.16
+26.40%
0.12
Current Deferred Liabilities
0.01
Current Deferred Revenue
0.01
Other Current Liabilities
0.83
-37.53%
1.33
+38.23%
0.96
+186.57%
0.34
Total Non Current Liabilities Net Minority Interest
8.76
-61.64%
22.84
+727.01%
2.76
-92.38%
36.23
Long Term Debt And Capital Lease Obligation
0.74
-96.18%
19.52
+4731.19%
0.40
-98.81%
33.96
Long Term Debt
18.72
33.40
Long Term Capital Lease Obligation
0.74
-7.11%
0.80
+98.51%
0.40
-28.50%
0.56
Other Non Current Liabilities
0.03
-96.97%
0.89
Preferred Securities Outside Stock Equity
19.97
Stockholders Equity
-11.77
+37.55%
-18.84
-960.92%
-1.78
+95.09%
-36.20
Common Stock Equity
-11.77
+37.55%
-18.84
-960.92%
-1.78
+95.09%
-36.20
Capital Stock
0.00
+50.00%
0.00
+0.00%
0.00
+100.00%
0.00
Common Stock
0.00
+50.00%
0.00
+0.00%
0.00
+100.00%
0.00
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
28.93
+35.68%
21.33
+8.81%
19.60
+0.26%
19.55
Ordinary Shares Number
28.93
+35.68%
21.33
+8.81%
19.60
+0.26%
19.55
Additional Paid In Capital
301.36
+13.29%
266.01
+4.08%
255.60
+34.59%
189.90
Retained Earnings
-313.40
-10.07%
-284.73
-10.68%
-257.26
-13.84%
-225.99
Gains Losses Not Affecting Retained Earnings
-0.12
+2.44%
-0.12
-4.24%
-0.12
-2.61%
-0.12
Other Equity Adjustments
-0.12
+2.44%
-0.12
-4.24%
-0.12
-2.61%
-0.12
Total Equity Gross Minority Interest
-11.77
+37.55%
-18.84
-960.92%
-1.78
+95.09%
-36.20
Total Capitalization
-11.77
-9238.89%
-0.13
+92.91%
-1.78
+36.53%
-2.80
Working Capital
-5.28
-489.03%
1.36
+694.15%
0.17
+119.63%
-0.87
Invested Capital
-11.77
-9238.89%
-0.13
+92.91%
-1.78
+24.43%
-2.35
Total Debt
0.92
-95.33%
19.66
+3398.40%
0.56
-98.37%
34.53
Net Debt
13.23
33.66
Capital Lease Obligations
0.92
-2.75%
0.94
+68.15%
0.56
-18.55%
0.69
Net Tangible Assets
-11.77
+37.55%
-18.84
-960.92%
-1.78
+95.09%
-36.20
Tangible Book Value
-11.77
+37.55%
-18.84
-960.92%
-1.78
+95.09%
-36.20
Derivative Product Liabilities
7.99
+228.44%
2.43
+3.18%
2.36
+3.88%
2.27
Interest Payable
0.00
-100.00%
0.70
Other Equity Interest
0.39
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-18.20
-1.40%
-17.95
-5.02%
-17.09
-94.11%
-8.80
Cash Flow From Continuing Operating Activities
-18.20
-1.40%
-17.95
-5.02%
-17.09
-94.11%
-8.80
Net Income From Continuing Operations
-23.76
-14.24%
-20.80
+30.50%
-29.92
-87.92%
-15.92
Depreciation Amortization Depletion
0.30
+74.57%
0.17
+30.08%
0.13
+77.33%
0.07
Depreciation
0.30
+74.57%
0.17
+30.08%
0.13
+77.33%
0.07
Depreciation And Amortization
0.30
+74.57%
0.17
+30.08%
0.13
+77.33%
0.07
Other Non Cash Items
2.76
+39.68%
1.98
-85.93%
14.05
+94.85%
7.21
Stock Based Compensation
0.74
+32.56%
0.56
-64.32%
1.57
0.00
Provisionand Write Offof Assets
0.04
-52.63%
0.08
+176.77%
-0.10
-141.46%
-0.04
Operating Gains Losses
-0.13
-118.22%
0.70
+137.84%
-1.84
-5362.86%
0.04
Gain Loss On Investment Securities
-0.13
-118.22%
0.70
+137.84%
-1.84
-5362.86%
0.04
Gain Loss On Sale Of PPE
0.00
Change In Working Capital
1.84
+388.24%
-0.64
+35.10%
-0.98
-514.38%
-0.16
Change In Receivables
0.77
+233.74%
-0.57
-179.02%
-0.20
-536.17%
0.05
Changes In Account Receivables
0.00
-87.50%
0.03
+210.34%
-0.03
-161.70%
0.05
Change In Inventory
0.13
+133.16%
-0.38
-3700.00%
-0.01
+94.85%
-0.19
Change In Prepaid Assets
-0.01
-188.89%
0.01
+101.06%
-0.85
-2344.74%
0.04
Change In Payables And Accrued Expense
2.22
+955.38%
-0.26
-156.89%
0.46
-3.79%
0.47
Change In Accrued Expense
0.84
+448.13%
-0.24
-156.38%
-0.09
-170.68%
0.13
Change In Payable
1.39
+7389.47%
-0.02
-103.45%
0.55
+61.11%
0.34
Change In Account Payable
1.39
+7389.47%
-0.02
-103.45%
0.55
+61.11%
0.34
Change In Other Current Liabilities
-1.27
-324.42%
0.56
+251.88%
-0.37
+29.28%
-0.53
Investing Cash Flow
-0.18
+81.73%
-0.98
-540.52%
-0.15
+29.82%
-0.22
Cash Flow From Continuing Investing Activities
-0.18
+81.73%
-0.98
-540.52%
-0.15
+29.82%
-0.22
Net PPE Purchase And Sale
-0.18
+81.73%
-0.98
-540.52%
-0.15
+29.82%
-0.22
Purchase Of PPE
-0.18
+81.73%
-0.98
-540.52%
-0.15
+29.82%
-0.22
Capital Expenditure
-0.18
+81.73%
-0.98
-540.52%
-0.15
+29.82%
-0.22
Financing Cash Flow
16.63
-17.65%
20.20
-5.09%
21.28
+163.00%
8.09
Cash Flow From Continuing Financing Activities
16.63
-17.65%
20.20
-5.09%
21.28
+163.00%
8.09
Net Issuance Payments Of Debt
9.17
-51.93%
19.08
+102.23%
9.44
+17.96%
8.00
Issuance Of Debt
10.00
-50.00%
20.00
+100.00%
10.00
+25.00%
8.00
Repayment Of Debt
-0.83
+9.72%
-0.92
-62.70%
-0.56
Long Term Debt Issuance
10.00
-50.00%
20.00
+100.00%
10.00
+25.00%
8.00
Long Term Debt Payments
-0.83
+9.72%
-0.92
-62.70%
-0.56
Net Long Term Debt Issuance
9.17
-51.93%
19.08
+102.23%
9.44
+17.96%
8.00
Net Common Stock Issuance
7.10
+306.53%
1.75
+1501.83%
0.11
0.00
Cash Dividends Paid
-1.82
+25.66%
-2.45
0.00
Proceeds From Stock Option Exercised
3.11
+71.40%
1.81
0.00
-100.00%
0.09
Net Other Financing Charges
-0.93
-1.53%
-0.92
-62.70%
-0.56
Changes In Cash
-1.75
-237.67%
1.27
-68.57%
4.04
+533.73%
-0.93
Effect Of Exchange Rate Changes
0.00
+160.00%
-0.01
-66.67%
-0.00
+57.14%
-0.01
Beginning Cash Position
5.48
+29.96%
4.22
+2205.46%
0.18
-83.68%
1.12
End Cash Position
3.74
-31.81%
5.48
+29.99%
4.22
+2204.92%
0.18
Free Cash Flow
-18.38
+2.90%
-18.93
-9.77%
-17.24
-91.11%
-9.02
Interest Paid Supplemental Data
0.04
-12.20%
0.04
+57.69%
0.03
0.00
Income Tax Paid Supplemental Data
0.00
0.00
0.00
Common Stock Issuance
7.10
+306.53%
1.75
+1501.83%
0.11
0.00
Issuance Of Capital Stock
7.10
+306.53%
1.75
-85.26%
11.85
0.00
Net Preferred Stock Issuance
0.00
-100.00%
11.74
0.00
Preferred Stock Dividend Paid
-1.82
+25.66%
-2.45
0.00
Preferred Stock Issuance
0.00
-100.00%
11.74
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category